BeStock  
Stocks › Biotechnology › REPL

Replimune REPL

US equityMarket cap rank #2747Biotechnology
$19.07 −$0.16 (-0.83%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $19.09 +0.10%
Open$18.84
Prev close$19.23
Day range$18.69 – $19.50
Volume1.96M
Market cap$1.81B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Sep 2026

Revenue$0.00
Operating profit-$56.04M+33.2% YoY
Net profit-$57.12M+31.3% YoY
Diluted EPS-$0.54+40.0% YoY
Free cash flow-$47.78M+42.1% YoY
Operating cash flow-$47.70M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-66.3MDec '24$-74.1MMar '25$-86.7MJun '25$-83.1MSep '25$-70.9MDec '25$-73.2MMar '26$-69.8MJun '26$-57.1MSep '26

Diluted EPS by quarter

-0.79Dec '24-0.82Mar '25-0.95Jun '25-0.90Sep '25-0.77Dec '25-0.76Mar '26-0.72Jun '26-0.54Sep '26

Free cash flow by quarter

$-52.5MDec '24$-54.9MMar '25$-79.8MJun '25$-82.6MSep '25$-66.1MDec '25$-56.2MMar '26$-75.7MJun '26$-47.8MSep '26

Annual revenue

$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25$0.0FY26

Profitability & balance sheet

Return on equity-115.8%
Return on assets-71.0%
Return on invested capital-77.4%
Current ratio7.11
Liabilities / assets45.2%
Cash & investments$307.83M
Total debt$123.15M
Net cash (debt)$184.68M

Income statement

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $56.04M $67.95M $318.32M $72.87M $71.53M
Selling and Admin Expenses $21.92M $18.97M $98.74M $21.01M $18.73M
Research & Development $34.37M $49.28M $221.18M $52.32M $53.14M
Other Operating Expenses -$238,000.00 -$296,000.00 -$1.60M -$466,000.00 -$341,000.00
Operating Profit -$56.04M -$67.95M -$318.32M -$72.87M -$71.53M
Net Non-Operating Interest Income (Expense) -$3.03M -$3.09M -$8.86M -$2.88M -$1.98M
Non-Operating Interest Expense $3.03M $3.09M $8.86M $2.88M $1.98M
Other Income (Expense) $1.95M $1.27M $12.68M $2.29M $2.27M
Gain on Sale of Security $1.88M $1.96M $13.63M $2.37M $2.85M
Other Non-Operating Income (Expenses) $67,000.00 -$688,000.00 -$942,000.00 -$77,000.00 -$580,000.00
Pretax Profit -$57.12M -$69.77M -$314.49M -$73.46M -$71.24M
Net Profit -$57.12M -$69.77M -$313.94M -$73.22M -$70.93M
Profit from Continuing Operations -$57.12M -$69.77M -$313.94M -$73.22M -$70.93M
Net Income to Parent Company -$57.12M -$69.77M -$313.94M -$73.22M -$70.93M
Net Income to Common Stockholders -$57.12M -$69.77M -$313.94M -$73.22M -$70.93M
Basic EPS -$0.54 -$0.72 -$3.38 -$0.76 -$0.77
Diluted EPS -$0.54 -$0.72 -$3.38 -$0.76 -$0.77
Tax – – -$551,000.00 -$240,000.00 -$311,000.00

Balance sheet

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Total Assets $373.94M $252.45M $332.39M $332.39M $333.59M
Total Current Assets $324.04M $200.81M $279.12M $279.12M $280.35M
Cash and Cash Equivalents & Short-Term Investments $307.83M $195.33M $268.89M $268.89M $269.14M
-Cash and Cash Equivalents $307.83M $185.36M $209.02M $209.02M $122.95M
-Short Term Investments $0.00 $9.97M $59.87M $59.87M $146.19M
Receivables $0.00 $0.00 $1.62M $1.62M $2.96M
Inventory $9.87M – – – –
Other Current Assets $6.34M $5.48M $8.61M $8.61M $8.26M
Total Non-Current Assets $49.91M $51.64M $53.27M $53.27M $53.24M
Net PPE $44.73M $46.70M $48.62M $48.62M $50.33M
-Gross PPE $63.17M $64.37M $65.36M $65.36M $66.29M
-Accumulated Depreciation -$18.44M -$17.67M -$16.73M -$16.73M -$15.96M
Other Non-Current Assets $5.18M $4.94M $4.65M $4.65M $2.90M
Total Liabilities $169.16M $146.80M $166.23M $166.23M $123.05M
Total Current Liabilities $45.55M $38.41M $58.23M $58.23M $50.09M
Payables $5.96M $4.26M $6.67M $6.67M $5.65M
-Accounts Payable $5.96M $4.26M $6.67M $6.67M $5.65M
Current Accrued Expenses $22.90M $22.95M $27.28M $27.28M $24.68M
Short-Term Debt and Capital Lease Obligation $4.04M $4.04M $4.04M $4.04M $4.08M
-Current Capital Lease Obligation $4.04M $4.04M $4.04M $4.04M $4.08M
Other Current Liabilities $3.91M $2.04M $2.76M $2.76M $1.24M
Total Non-Current Liabilities $123.61M $108.39M $108.00M $108.00M $72.96M
Long Term Debt and Capital Lease Obligation $123.15M $107.94M $107.55M $107.55M $72.27M
-Long Term Debt $99.77M $84.11M $83.31M $83.31M $47.63M
-Long Term Capital Lease Obligation $23.39M $23.82M $24.24M $24.24M $24.64M
Other Non-Current Liabilities $455,000.00 $455,000.00 $455,000.00 $455,000.00 $693,000.00
Total Equity $204.78M $105.65M $166.16M $166.16M $210.54M
Stockholders' Equity $204.78M $105.65M $166.16M $166.16M $210.54M
Capital Stock $95,000.00 $84,000.00 $82,000.00 $82,000.00 $79,000.00
-Common Stock $95,000.00 $84,000.00 $82,000.00 $82,000.00 $79,000.00
Additional Paid-In Capital $1.59B $1.43B $1.42B $1.42B $1.39B
Retained Earnings -$1.39B -$1.33B -$1.26B -$1.26B -$1.19B
Gains/Losses Not Affecting Retained Earnings $5.92M $5.98M $5.40M $5.40M $5.56M
-Other Receivables – – $1.62M $1.62M $2.96M

Cash flow

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Operating Cash Flow -$47.70M -$75.73M -$280.34M -$56.16M -$65.96M
Net cash flow from continuing operations -$47.70M -$75.73M -$280.34M -$56.16M -$65.96M
Net Income from Continuing Operations -$57.12M -$69.77M -$313.94M -$73.22M -$70.93M
Gain/Loss from Continuing Operations $67,000.00 -$688,000.00 -$942,000.00 -$77,000.00 -$581,000.00
Depreciation & Depletion & Amortization $773,000.00 $937,000.00 $3.33M $769,000.00 $848,000.00
Other Non-Cash Items $1.47M $1.62M $5.13M $1.49M $1.23M
Change in Working Capital -$4.18M -$15.50M -$3.84M $6.88M -$3.43M
-Change in Receivables -$233,000.00 $1.35M $451,000.00 -$464,000.00 -$349,000.00
-Change in Prepaid Assets -$851,000.00 $3.13M -$232,000.00 -$362,000.00 $36,000.00
-Change in Payables and Accrued Expense $7.00M -$19.76M -$2.76M $7.82M -$2.64M
-Change in Other Current Liabilities -$226,000.00 -$218,000.00 -$1.31M -$116,000.00 -$475,000.00
Net cash flow from investing $9.76M $49.99M $310.84M $86.51M $75.12M
Net Cash Flow from Continuing Investing Activities $9.76M $49.99M $310.84M $86.51M $75.12M
Net PPE Purchase and Sale $3,000.00 -$6,000.00 -$4.22M -$5,000.00 -$135,000.00
Net Investment Purchase and Sale $9.76M $50.00M $315.07M $86.51M $75.26M
Financing Cash Flow $160.55M $800,000.00 $66.29M $55.68M $10.45M
Net Cash Flow from Continuing Financing Activities $160.55M $800,000.00 $66.29M $55.68M $10.45M
Net Issuance Payments Of Debt $14.79M -$203,000.00 $34.26M $34.80M -$195,000.00
Proceeds from Stock Option Exercised $35.78M $1.00M $883,000.00 $92,000.00 $282,000.00
Ending Cash Balance $309.54M $187.06M $210.73M $210.73M $124.66M
Net Change in Cash $122.61M -$24.94M $96.79M $86.02M $19.62M
Beginning Cash Balance $187.06M $210.73M $112.82M $124.66M $104.00M
Effect of Exchange Rate Changes -$136,000.00 $1.27M $1.11M $50,000.00 $1.04M
Free Cash Flow -$47.78M -$75.73M -$284.57M -$56.17M -$66.09M
-Change in Other Current Assets – – $0.00 $0.00 $0.00
Net Common Stock Issuance – – $31.15M $20.78M $10.36M

Discussion

No comments yet — be the first to weigh in on REPL.

Sign in to join the discussion.

Scroll to Top